SET
0337
SUNLOGY
0345
TECHSTORE
0343
COLFORM
0341
CBHB
0339
MY Stock MarketDetailed Quotes
0252 ORGABIO
- 0.355
- +0.005+1.43%
15min DelayMarket Closed Mar 28 16:13 CST
87.99MMarket Cap16.14P/E (TTM)
0.355High0.350Low210.30KVolume0.350Open0.350Pre Close73.96KTurnover0.52052wk High0.50%Turnover Ratio247.87MShares0.28052wk Low0.022EPS TTM14.89MFloat Cap0.520Historical High20.88P/E (Static)41.93MShs Float0.225Historical Low0.017EPS LYR1.43%Amplitude--Dividend TTM1.51P/B100Lot Size--Div YieldTTM
ORGABIO Key Stats
Quarterly+Annual
YOY
| (Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (Q3)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 36.15%25.4M | 92.93%23.44M | 26.01%74.14M | 58.08%20.9M | 82.08%22.43M | -0.86%18.66M | -16.06%12.15M | -8.58%58.84M | -17.49%13.22M | -8.64%12.32M |
| Cost of revenue | 43.82%21.49M | 90.41%18.91M | 23.05%60.26M | 54.20%17.34M | 68.65%18.06M | -8.51%14.94M | -7.15%9.93M | -3.01%48.97M | -7.84%11.24M | 7.93%10.71M |
| Gross profit | 5.35%3.92M | 104.19%4.53M | 40.71%13.87M | 80.03%3.57M | 171.37%4.37M | 49.40%3.72M | -41.25%2.22M | -28.85%9.86M | -48.22%1.98M | -54.80%1.61M |
| Operating expense | 17.94%2.35M | 7.73%1.95M | -15.88%7.95M | 26.65%2.11M | -7.32%2.03M | 18.26%2M | -53.59%1.81M | 62.81%9.45M | -3.98%1.67M | 36.35%2.19M |
| Selling and administrative expenses | 17.94%2.35M | 7.73%1.95M | -15.88%7.95M | 26.65%2.11M | -7.32%2.03M | 18.26%2M | -53.59%1.81M | 62.81%9.45M | -3.98%1.67M | 36.35%2.19M |
| -Selling and marketing expense | -16.67%10K | 475.00%23K | 157.49%20.51K | 7,268.57%2.51K | -33.33%2K | --12K | 0.00%4K | 26.83%7.97K | -112.50%-35 | -50.00%3K |
| -General and administrative expense | 18.15%2.34M | 6.69%1.93M | -16.02%7.93M | 26.50%2.11M | -7.28%2.03M | 17.55%1.98M | -53.64%1.81M | 62.85%9.44M | -3.97%1.67M | 36.67%2.18M |
| Operating profit | -9.23%1.56M | 532.60%2.58M | 1,336.69%5.93M | 364.11%1.46M | 505.89%2.34M | 114.98%1.72M | 426.40%408K | -94.88%412.57K | -85.00%313.57K | -129.47%-577K |
| Net non-operating interest income (expenses) | -7.25%-148K | 4.52%-148K | 6.28%-556.93K | 5.14%-134.93K | 9.15%-129K | 13.75%-138K | -3.33%-155K | -3.81%-594.23K | 5.45%-142.23K | -0.71%-142K |
| Non-operating interest expense | 7.25%148K | -4.52%148K | -6.28%556.93K | -5.14%134.93K | -9.15%129K | -13.75%138K | 3.33%155K | 3.81%594.23K | -5.45%142.23K | 0.71%142K |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -223.53%-55K | -3,600.00%-37K | -58.13%-18.07K | -9.75%5.93K | -127.78%-5K | 19.05%-17K | -133.33%-1K | -565.57%-11.43K | 176.94%6.58K | 18K |
| Less:Write off | 223.53%55K | 3,600.00%37K | 58.13%18.07K | 9.75%-5.93K | 127.78%5K | -19.05%17K | 133.33%1K | 565.57%11.43K | -176.94%-6.58K | ---18K |
| Other non-operating income (expenses) | 204.91%497K | -467.50%-681K | -14.41%294.56K | -80.67%94.56K | 222.45%158K | 143.47%163K | -173.62%-120K | -32.82%344.16K | 18.36%489.16K | 226.67%49K |
| Income before tax | 7.34%1.86M | 1,199.24%1.72M | 3,637.93%5.65M | 113.00%1.42M | 462.88%2.37M | 606.12%1.73M | 221.10%132K | -98.11%151.07K | -71.55%667.07K | -135.59%-652K |
| Income tax | -22.13%591K | 650.00%645K | 48.83%1.54M | 1,131.93%447.96K | 161.70%246K | 224.36%759K | -87.13%86K | -53.80%1.03M | -94.56%36.36K | -79.25%94K |
| Net income | 30.38%1.27M | 2,226.09%1.07M | 565.71%4.11M | 54.25%972.89K | 384.18%2.12M | 8,727.27%971K | 105.92%46K | -115.31%-882.29K | -62.37%630.71K | -154.10%-746K |
| Net income continuous operations | 30.38%1.27M | 2,226.09%1.07M | 565.71%4.11M | 54.25%972.89K | 384.18%2.12M | 8,727.27%971K | 105.92%46K | -115.31%-882.29K | -62.37%630.71K | -154.10%-746K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 30.38%1.27M | 2,226.09%1.07M | 565.71%4.11M | 54.25%972.89K | 384.18%2.12M | 8,727.27%971K | 105.92%46K | -115.31%-882.29K | -62.37%630.71K | -154.10%-746K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 30.38%1.27M | 2,226.09%1.07M | 565.71%4.11M | 54.25%972.89K | 384.18%2.12M | 8,727.27%971K | 105.92%46K | -115.31%-882.29K | -62.37%630.71K | -154.10%-746K |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 30.77%0.0051 | 2,050.00%0.0043 | 561.11%0.0166 | 53.85%0.004 | 383.33%0.0085 | 3,800.00%0.0039 | 106.25%0.0002 | -115.49%-0.0036 | -61.55%0.0026 | -153.93%-0.003 |
| Diluted earnings per share | 30.77%0.0051 | 2,050.00%0.0043 | 561.11%0.0166 | 53.85%0.004 | 383.33%0.0085 | 3,800.00%0.0039 | 106.25%0.0002 | -115.49%-0.0036 | -61.55%0.0026 | -153.93%-0.003 |
| Dividend per share | ||||||||||
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.